113 related articles for article (PubMed ID: 2692895)
1. Small nuclear RNA associated proteins: autoantigens in connective tissue diseases.
Van Venrooij WJ; Sillekens PT
Clin Exp Rheumatol; 1989; 7(6):635-45. PubMed ID: 2692895
[TBL] [Abstract][Full Text] [Related]
2. [Value of the characterization of anti-ribonucleoproteins and anti-Sm antibodies by immunoblotting and immunoprecipitation in connectivitis].
Combe B; Lussiez V; Rucheton M; Graafland H; Brunel C; Sany J
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):47-9. PubMed ID: 3281242
[No Abstract] [Full Text] [Related]
3. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
4. Novel human autoantibodies reactive with 5'-terminal trimethylguanosine cap structures of U small nuclear RNA.
Okano Y; Medsger TA
J Immunol; 1992 Aug; 149(3):1093-8. PubMed ID: 1634764
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme immunoassay for the detection of autoantibodies to nRNP and Sm: a rapid and sensitive alternative to current procedures].
Blazek M; Naser W; Bayer-Beck J; Lakomek HJ; Werle E; Fiehn W
Z Rheumatol; 1992; 51(2):87-93. PubMed ID: 1615735
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases.
Op De Beéck K; Maes L; Van den Bergh K; Derua R; Waelkens E; Van Steen K; Vermeersch P; Westhovens R; De Vlam K; Verschueren P; Hooijkaas H; Blockmans D; Bossuyt X
Arthritis Rheum; 2012 Jan; 64(1):213-21. PubMed ID: 21905010
[TBL] [Abstract][Full Text] [Related]
7. [Presence of autoantibodies and the clinical course of systemic lupus erythematosus].
Prokop J; Zietkiewicz E; Słomski R
Przegl Dermatol; 1986; 73(3):238-44. PubMed ID: 3541063
[No Abstract] [Full Text] [Related]
8. [Autoantibodies to the heterogeneous nuclear ribonucleoproteins and the autoimmune diseases].
Yang L; Yu M; Yang C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):311-4. PubMed ID: 12567457
[TBL] [Abstract][Full Text] [Related]
9. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies--what do they recognize?
Tan EM
Verh Dtsch Ges Pathol; 1996; 80():1-11. PubMed ID: 9020568
[No Abstract] [Full Text] [Related]
11. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
Riemekasten G; Hiepe F
Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
[No Abstract] [Full Text] [Related]
12. Clinical course of patients with anti-RNP antibodies.
Snowden N; Hay E; Holt PJ; Bernstein R
J Rheumatol; 1993 Jul; 20(7):1256-8. PubMed ID: 8371236
[No Abstract] [Full Text] [Related]
13. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.
Klein Gunnewiek JM; van de Putte LB; van Venrooij WJ
Clin Exp Rheumatol; 1997; 15(5):549-60. PubMed ID: 9307865
[TBL] [Abstract][Full Text] [Related]
14. Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
van Venrooij WJ; Hoet R; Castrop J; Hageman B; Mattaj IW; van de Putte LB
J Clin Invest; 1990 Dec; 86(6):2154-60. PubMed ID: 1701452
[TBL] [Abstract][Full Text] [Related]
15. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
[TBL] [Abstract][Full Text] [Related]
16. The purification, characterization and amino acid analysis of nuclear ribonuclear protein and Sm antigens reacting with human autoimmune sera.
Fritzler MJ; O'Brien MD
Clin Invest Med; 1983; 6(2):61-71. PubMed ID: 6883833
[TBL] [Abstract][Full Text] [Related]
17. The composition of the nuclear antigens Sm and RNP of human rheumatic and connective tissue diseases and the relevance of their autoantibodies as probes for RNA processing mechanisms.
MacGillivray AJ; Carroll AR; Dahi S; Naxakis G; Sadaie MR; Wallis CM; Jing T
FEBS Lett; 1982 May; 141(2):139-47. PubMed ID: 6178619
[No Abstract] [Full Text] [Related]
18. Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases.
Nishikai M; Sekiguchi S
Arthritis Rheum; 1985 May; 28(5):579-81. PubMed ID: 4004965
[No Abstract] [Full Text] [Related]
19. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
[TBL] [Abstract][Full Text] [Related]
20. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.
Sabbatini A; Dolcher MP; Marchini B; Bombardieri S; Migliorini P
J Rheumatol; 1993 Oct; 20(10):1679-83. PubMed ID: 7507527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
